Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oseaspre Consultants Limited has sold its entire holding of 48,000 equity shares in INOR Medical Products Limited, an unlisted company, to Nowrosjee Wadia and Sons Limited. The disclosure was made under Regulation 30 of SEBI LODR Regulations, 2015, and signed by Company Secretary Ganesh S. Pardeshi on 25th February 2026. No financial details such as the sale price or consideration amount have been disclosed in this filing. INOR Medical Products is not a listed entity, and the transaction appears to be a portfolio investment sale by the company.
This is a minor portfolio transaction involving an unlisted associate and is unlikely to have any material impact on the stock price or shareholder value of Oseaspre Consultants. Investors may await further details on the sale consideration to gauge any financial impact.